Fig. 4
From: Preliminary insights into RNA in CSF of pediatric SMA patients after 6 months of nusinersen
Selected DE cfRNAs in SMA “heterogeneous” and “homogenous” patients, subdivided into “disease specific” (A), “treatment specific” (B) and “treatment dependent” (C) for the “heterogeneous” group, and reported in the same graph for “homogeneous” group (“disease specific” in black and “treatment specific” in red. On x-axis, the log2 Fold Change is reported, while on y-axis the corresponding DE transcript is indicated